menu
    • menu

    Find Dexchloropheniramine Maleate manufacturers, exporters & distributors on PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    11

    API Suppliers

    API Suppliers

    6

    USDMF

    US DMFs Filed

    1

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    3

    EU WC

    EU WC

    3

    KDMF

    KDMF

    3

    NDC API

    NDC API

    0

    VMF

    NDC API

    7

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    7

    API

    1

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    22

    FDF Dossiers

    FDF Dossiers

    14

    FDA Orange Book

    FDA (Orange Book)

    2

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    3

    South Africa

    South Africa

    3

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    1

    EDQM

    1

    USP

    0

    JP

    1

    Others

    PATENTS & EXCLUSIVITIES

    2

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    4

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    145 RELATED EXCIPIENT COMPANIES

    232EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 2438-32-6, Polaramine, (+)-chlorpheniramine maleate, D-chlorpheniramine maleate, Dexchloropheniramine maleate, Mylaramine
    Molecular Formula
    C20H23ClN2O4
    Molecular Weight
    390.9  g/mol
    InChI Key
    DBAKFASWICGISY-DASCVMRKSA-N
    FDA UNII
    B10YD955QW
    Dexchloropheniramine Maleate
    Dexchlorpheniramine Maleate is the maleate salt form of dexchlorpheniramine, an alkylamine, and first-generation histamine antagonist with anti-allergic activity. Dexchlorpheniramine maleate competitively blocks H1 receptors, thereby preventing the actions of histamine on bronchial smooth muscle, capillaries and gastrointestinal (GI) smooth muscle. This prevents histamine-induced bronchoconstriction, vasodilation, increased capillary permeability, and GI smooth muscle spasms.
    1 2D Structure

    Dexchloropheniramine Maleate

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (Z)-but-2-enedioic acid;(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
    2.1.2 InChI
    InChI=1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t15-;/m0./s1
    2.1.3 InChI Key
    DBAKFASWICGISY-DASCVMRKSA-N
    2.1.4 Canonical SMILES
    CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O
    2.1.5 Isomeric SMILES
    CN(C)CC[C@@H](C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=C\C(=O)O)\C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    B10YD955QW
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Dexchlorpheniramine

    2. Dexchlorpheniramine Maleate (1:1), (+-)-isomer

    3. Dexchlorpheniramine Maleate (1:1), (r)-isomer

    4. Dexchlorpheniramine Maleate (1:1), (s)-isomer

    5. Dexchlorpheniramine Monohydrochloride

    6. Dexchlorpheniramine Sodium Maleate (1:1)

    7. Dexchlorpheniramine, (+-)-isomer

    8. Dexchlorpheniramine, (r)-isomer

    9. Dexchlorpheniramine, Monohydrochloride, (s)-isomer

    10. Dexclor

    11. Dexclorfeniramine

    12. Dextrochlorpheniramine Maleate

    13. Polaramin

    14. Polaramine

    15. Polargen Td

    16. Polaronil

    2.3.2 Depositor-Supplied Synonyms

    1. 2438-32-6

    2. Polaramine

    3. (+)-chlorpheniramine Maleate

    4. D-chlorpheniramine Maleate

    5. Dexchloropheniramine Maleate

    6. Mylaramine

    7. Dexchlorpheniramine (maleate)

    8. Chlorpheniramine D-form Maleate

    9. S-(+)-chlorpheniramine Maleate Salt

    10. Dexchlorpheniramine Maleate, Usp

    11. Chebi:4465

    12. B10yd955qw

    13. Chlorpheniramine Maleate, (s)-

    14. Dexchlorpheniramine Maleate [usp]

    15. (z)-but-2-enedioic Acid;(3s)-3-(4-chlorophenyl)-n,n-dimethyl-3-pyridin-2-ylpropan-1-amine

    16. Nsc-759156

    17. Dextrochlorpheniramine Maleate

    18. Dexchlorpheniramine Maleate (usp)

    19. (s)-3-(4-chlorophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine Maleate

    20. (gamma-(4-chlorophenyl)-pyridine-2-propyl)(dimethyl)ammonium Hydrogen (z)-maleate

    21. Sr-01000075763

    22. Unii-b10yd955qw

    23. Polar Amine

    24. S-(+)-chlorpheniramine Maleate

    25. Rescon Jr

    26. Rescon Mx

    27. Mylaramine (tn)

    28. Polaramine (tn)

    29. (s)-chlorpheniramine Maleate Salt

    30. Einecs 219-450-6

    31. Mfcd00079046

    32. Dexchlorpheniraminmaleat

    33. Mls001401384

    34. Schembl119500

    35. Chembl1200927

    36. Dtxsid001017216

    37. Hms2052e15

    38. Hms2233i15

    39. Hms3260f10

    40. D-chlorpheniramine Maleate (jp17)

    41. Hy-b1062

    42. Tox21_500264

    43. Bdbm50247890

    44. (+)-2-(p-chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate (1:1)

    45. Akos015962825

    46. Ccg-101121

    47. Cs-4618

    48. Db09555

    49. Lp00264

    50. Nc00371

    51. Nsc 759156

    52. (2z)-but-2-enedioic Acid; [(3s)-3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine

    53. D-chlorpheniramine Maleate [jan]

    54. Ncgc00093722-01

    55. Ncgc00093722-02

    56. Ncgc00093722-03

    57. Ncgc00260949-01

    58. 2-pyridinepropanamine, .gamma.-(4-chlorophenyl)-n,n-dimethyl-, (s)-, (z)-2-butenedioate (1:1)

    59. Ac-19009

    60. As-17464

    61. Smr000471617

    62. Dexchlorpheniramine Maleate [vandf]

    63. Dexchlorpheniramine Maleate [usp-rs]

    64. Dexchlorpheniramine Maleate [who-dd]

    65. Chlorpheniramine D-form Maleate [mi]

    66. Eu-0100264

    67. C 4915

    68. C07783

    69. D00668

    70. Dexchlorpheniramine Maleate [ep Impurity]

    71. Dexchlorpheniramine Maleate [orange Book]

    72. 438d326

    73. A924268

    74. Dexchlorpheniramine Maleate [ep Monograph]

    75. Dexchlorpheniramine Maleate [usp Monograph]

    76. Sr-01000075763-1

    77. Sr-01000075763-4

    78. Q27106393

    79. (gammas)-gamma-(4-chlorophenyl)-n,n-dimethyl-2-pyridinepropanamine Maleate

    80. Dexchlorpheniramine Maleate, European Pharmacopoeia (ep) Reference Standard

    81. Gammas-(4-chlorophenyl)-n,n-dimethyl-2-pyridinepropanamine, 2z-butenedioate

    82. (+)-2-(p-chloro-.alpha.-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate (1:1)

    83. Dexchlorpheniramine Maleate, United States Pharmacopeia (usp) Reference Standard

    84. Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethyl)benzyl)-, Maleate (1:1), (+)-

    85. 2-pyridinepropanamine, Gamma-(4-chlorophenyl)-n,n-dimethyl-, (s)-, (z)-2-butenedioate (1:1)

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 390.9 g/mol
    Molecular Formula C20H23ClN2O4
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count7
    Exact Mass390.1346349 g/mol
    Monoisotopic Mass390.1346349 g/mol
    Topological Polar Surface Area90.7 Ų
    Heavy Atom Count27
    Formal Charge0
    Complexity368
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameDexchlorpheniramine maleate
    PubMed HealthDexchlorpheniramine Maleate (By mouth)
    Drug ClassesRespiratory Agent
    Drug LabelEach 5 mL (teaspoonful) contains:Dexchlorpheniramine Maleate, USP2 mgAlcohol not more than7.0%Dexchlorpheniramine Maleate, USP, an antihistamine agent, is a white, odorless crystalline powder that is freely soluble in water. The molecular formula is...
    Active IngredientDexchlorpheniramine maleate
    Dosage FormSyrup
    RouteOral
    Strength2mg/5ml
    Market StatusPrescription
    CompanyWockhardt

    2 of 2  
    Drug NameDexchlorpheniramine maleate
    PubMed HealthDexchlorpheniramine Maleate (By mouth)
    Drug ClassesRespiratory Agent
    Drug LabelEach 5 mL (teaspoonful) contains:Dexchlorpheniramine Maleate, USP2 mgAlcohol not more than7.0%Dexchlorpheniramine Maleate, USP, an antihistamine agent, is a white, odorless crystalline powder that is freely soluble in water. The molecular formula is...
    Active IngredientDexchlorpheniramine maleate
    Dosage FormSyrup
    RouteOral
    Strength2mg/5ml
    Market StatusPrescription
    CompanyWockhardt

    4.2 Drug Indication

    Dexchlorpheniramine can be used in the treatment of perennial and seasonal allergic rhinitis, vasomotor rhiniti, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticaria and angioedema, amelioration of allergic reactions to blood or plasma, and dermographism.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    In allergic reactions, an allergen binds to IgE antibodies on mast cells and basophils. Once this occurs IgE receptors crosslink with each other triggering a series of events that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H1-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Dexchlorpheniramine, is a histamine H1 antagonist of the alkylamine class. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.

    5.2 MeSH Pharmacological Classification

    Histamine H1 Antagonists

    Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)

    5.3 Absorption, Distribution and Excretion

    Absorption

    Oral bioavailability in rats 40.5%

    Route of Elimination

    Renal excretion

    Volume of Distribution

    321L

    Clearance

    9.8L/h

    5.4 Metabolism/Metabolites

    Hepatic metabolism. Major metabolism by CYP 2D6 and minor metabolism by 3A4, 2C11 and 2B1.

    5.5 Biological Half-Life

    20-30 h

    5.6 Mechanism of Action

    Competes with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Dexchlorpheniramine is the predominant active isomer of chlorpheniramine and is approximately twice as active as the racemic compound.

    API SUPPLIERS

    read-more
    read-more

    01

    Gonane Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Booth #2.A34
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Gonane Pharma

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Jai Radhe Sales

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Jai Radhe Sales

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Pharm-RX Chemical

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Pharm RX

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Supriya Lifescience

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI India 2024
    Booth #1.B20
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 35855

    Submission : 2021-04-17

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-29

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-0218

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 61281-3400

    Start Marketing Date : 2013-11-21

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF arrow-down
    ✖

    Registrant Name : IMCD Korea Co., Ltd.

    Registration Date : 2024-09-11

    Registration Number : 20210302-211-J-852(2)

    Manufacturer Name : Supriya Lifescience Ltd.

    Manufacturer Address : A-5/2, Lote Parshuram Industrial Area, MIDC Tal-Khed. Dist-Ratnagiri, Maharashtra, Pin-415 722, India

     VMF Others AUDIT
    Supriya

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Mallinckrodt Pharmaceuticals

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Mallinckrodt Pharmaceuticals

    Ireland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    euroPLX 86 Munich
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 24848

    Submission : 2011-09-30

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Kongo Chemical Co., Ltd.

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Kongo Chemical Co., Ltd.

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    euroPLX 86 Munich
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-10-27

    Pay. Date : 2014-05-13

    DMF Number : 4688

    Submission : 1982-10-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-124 - Rev 00

    Issue Date : 2020-09-04

    Type : Chemical

    Substance Number : 1196

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 12294-0010

    Start Marketing Date : 1977-02-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Keshava Organics

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Keshava Organics

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    euroPLX 86 Munich
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21355

    Submission : 2008-02-05

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-12-09

    Valid Till : 2025-07-02

    Written Confirmation Number : WC-244

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Merck & Co

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Merck & Co

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    euroPLX 86 Munich
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4298

    Submission : 1981-10-22

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Industriale Chimica

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Industriale Chimica

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    euroPLX 86 Munich
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5328

    Submission : 1984-03-30

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Halcyon Labs Private Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Halcyon Labs Private Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    euroPLX 86 Munich
    Not Confirmed
    USDMF CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2020-02-24

    Valid Till : 2022-07-02

    Written Confirmation Number : WC-241

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - ...DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 19111

    read-more

    DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - ...DOSAGE - SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML

    USFDA APPLICATION NUMBER - 207768

    read-more

    DOSAGE - SYRUP;ORAL - 2MG/5ML

    USFDA APPLICATION NUMBER - 88251

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Granulation

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Topical

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Soft Gelatin

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search